Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-10 Sale |
2021-02-12 5:03 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
183,051 | $20 | $3,661,020 | 7,136,728 (Indirect) |
View |
2021-02-05 Sale |
2021-02-09 6:14 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
91,700 | $20.06 | $1,839,337 | 7,319,779 (Indirect) |
View |
2021-02-02 Sale |
2021-02-04 7:30 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
120,073 | $20.22 | $2,427,558 | 7,411,479 (Indirect) |
View |
2021-01-25 Sale |
2021-01-27 8:35 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
721,194 | $20.02 | $14,441,349 | 7,531,552 (Indirect) |
View |
2021-01-20 Sale |
2021-01-22 8:16 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
68,455 | $22.51 | $1,540,761 | 8,354,392 (Indirect) |
View |
2021-01-04 Sale |
2021-01-06 6:25 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $18.38 | $183,837 | 63,858 (Direct) |
View |
2020-10-01 Sale |
2020-10-05 4:25 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $16.27 | $162,737 | 73,675 (Direct) |
View |
2020-08-18 Purchase |
2020-08-20 6:36 pm |
Harpoon Therapeutics Inc. | HARP | Erbez Georgia Chief Financial Officer |
7,098 | $11.46 | $81,337 | 62,907 (Indirect Direct) |
View |
2020-07-31 Purchase |
2020-08-04 08:32 am |
Harpoon Therapeutics Inc. | HARP | Erbez Georgia Chief Financial Officer |
1,817 | $10.92 | $19,842 | 55,809 (Indirect Direct) |
View |
2020-07-01 Sale |
2020-07-02 7:18 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $16.2 | $161,989 | 83,675 (Direct) |
View |
2020-05-27 Sale |
2020-05-29 4:32 pm |
Harpoon Therapeutics Inc. | HARP | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
378,655 | $21.37 | $8,091,070 | 2,193,704 (Indirect) |
View |
2020-05-18 Sale |
2020-05-20 6:34 pm |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
1,522 | $14.77 | $22,479 | 91,379 (Direct) |
View |
2020-05-12 Sale |
2020-05-13 8:45 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,400 | $14.09 | $19,720 | 93,675 (Direct) |
View |
2020-05-07 Sale |
2020-05-11 9:37 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
7,350 | $14.1 | $103,641 | 182,887 (Direct) |
View |
2020-05-01 Sale |
2020-05-05 4:35 pm |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
5,826 | $12.07 | $70,301 | 214,680 (Direct) |
View |
2020-04-28 Sale |
2020-04-30 4:58 pm |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,250 | $14.05 | $17,565 | 102,425 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-28 Option Award |
2021-01-29 8:02 pm |
N/A 2031-01-27 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
52,000 | $0 | 52,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 8:00 pm |
N/A 2031-01-27 |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 7:55 pm |
N/A 2031-01-27 |
Harpoon Therapeutics Inc. | HARP | Erbez Georgia Chief Financial Officer |
72,000 | $0 | 72,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 7:53 pm |
N/A 2031-01-27 |
Harpoon Therapeutics Inc. | HARP | McMahon Gerald PhD President and CEO |
181,470 | $0 | 181,470 (Direct) |
View |
2021-01-20 Other |
2021-01-22 8:16 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
101,646 | $0 | 8,354,392 (Indirect) |
View |
2021-01-04 Exercise |
2021-01-06 6:25 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0.6 | 63,858 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 6:25 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0 | 63,858 (Direct) |
View |
2020-10-01 Exercise |
2020-10-05 4:25 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0.6 | 73,675 (Direct) |
View |
2020-10-01 Exercise |
2020-10-05 4:25 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0 | 73,675 (Direct) |
View |
2020-07-01 Exercise |
2020-07-02 7:18 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0.6 | 83,675 (Direct) |
View |
2020-07-01 Exercise |
2020-07-02 7:18 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
10,000 | $0 | 83,675 (Direct) |
View |
2020-07-01 Option Award |
2020-07-02 6:49 pm |
N/A 2030-06-30 |
Harpoon Therapeutics Inc. | HARP | Viney Joanne L. Director |
20,335 | $0 | 20,335 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:50 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director |
10,167 | $0 | 10,167 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:47 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | EASTLAND JULIA MARIE Director |
10,167 | $0 | 10,167 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:45 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director 10% Owner |
15,073 | $0 | 15,073 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:42 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director |
13,047 | $0 | 13,047 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:41 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director |
13,184 | $0 | 13,184 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:38 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | Baeuerle Patrick Director |
12,751 | $0 | 12,751 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:36 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director 10% Owner |
13,754 | $0 | 13,754 (Direct) |
View |
2020-05-18 Exercise |
2020-05-20 6:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
1,522 | $2.12 | 91,379 (Direct) |
View |
2020-05-18 Exercise |
2020-05-20 6:34 pm |
N/A 2028-11-16 |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
1,522 | $0 | 91,379 (Direct) |
View |
2020-05-12 Exercise |
2020-05-13 8:45 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,400 | $0.6 | 93,675 (Direct) |
View |
2020-05-12 Exercise |
2020-05-13 8:45 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,400 | $0 | 93,675 (Direct) |
View |
2020-05-07 Exercise |
2020-05-11 9:37 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
7,350 | $0.6 | 182,887 (Direct) |
View |
2020-05-07 Exercise |
2020-05-11 9:37 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
7,350 | $0 | 182,887 (Direct) |
View |
2020-05-01 Exercise |
2020-05-05 4:35 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
5,826 | $2.12 | 214,680 (Direct) |
View |
2020-05-01 Exercise |
2020-05-05 4:35 pm |
N/A 2028-10-17 |
Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer |
5,826 | $0 | 214,680 (Direct) |
View |
2020-04-28 Exercise |
2020-04-30 4:58 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,250 | $0.6 | 102,425 (Direct) |
View |
2020-04-28 Exercise |
2020-04-30 4:58 pm |
N/A 2027-01-13 |
Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer |
1,250 | $0 | 102,425 (Direct) |
View |